DaVita Inc Dossier
Qualitative Analysis
Business overview
DaVita Inc. is a leading provider of kidney care services in the United States and internationally, specializing in outpatient dialysis services for patients suffering from chronic kidney failure and end-stage renal disease (ESRD). As of early 2026, the company operates over 3,200 outpatient dialysis centers globally, serving approximately 296,000 patients. DaVita's business model relies heavily on treatment volumes and per-treatment reimbursement rates, with government payers (primarily Medicare) dominating its U.S. dialysis patient service revenue. The company is also actively expanding its footprint in home-based dialysis models and integrated kidney care (IKC) arrangements.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Expanding risk-based integrated care arrangements to manage the total cost of care for chronic kidney disease patients.
Expected impact: Aims to improve clinical outcomes, reduce hospitalizations, and transition the IKC segment to profitability.
Prioritizing and investing in home-based dialysis solutions (peritoneal dialysis and home hemodialysis) to offer patient-preferred and cost-effective care.
Expected impact: Provides a more flexible treatment schedule for patients, improves clinical outcomes, and optimizes operational efficiency.
Deploying a new AI-driven scheduling tool called Schedule Hub to optimize clinic capacity and labor productivity.
Expected impact: Improves labor efficiency and clinic utilization, helping to offset wage inflation.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
Acquired control of the APAC joint venture through a change in control rights for no cash consideration, expanding international operations.
Financial impact: Recognized a non-cash gain of $59 million on previously held equity interests and a related foreign currency gain of $15 million.
Strategic Partnerships
Co-developing a specialized, kidney-focused in-home care model to expand access to high-acuity care at home and reduce preventable hospitalizations.
Terms: DaVita and Ares are making a strategic investment in Elara Caring; terms of the transaction were not disclosed, though reports indicate a minority investment.